Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Zabbarova

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Interventions|January 16, 2009
Targeted delivery of radioprotective agents to mitochondriaIrina Zabbarova, Anthony Kanai
Organic & Biomolecular Chemistry|January 6, 2007
Mitochondrial targeting of radioprotectants using peptidyl conjugatesAnthony Kanai, Irina Zabbarova, Andrew Amoscato, et al.
Life Sciences|December 7, 2021
Role of hyperpolarization-activated cyclic nucleotide-gated channels in aging bladder phenotypeNishant Singh, Irina Zabbarova, Youko Ikeda, et al.
Neurourology and Urodynamics|January 26, 2012
Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011Anthony Kanai, Irina Zabbarova, Michael Oefelein, et al.
Neurourology and Urodynamics|May 20, 2014
Do we understand any more about bladder interstitial cells?-ICI-RS 2013Anthony Kanai, Christopher Fry, Ann Hanna-Mitchell, et al.
Neurourology and Urodynamics|June 11, 2011
Sophisticated models and methods for studying neurogenic bladder dysfunctionAnthony Kanai, Irina Zabbarova, Youko Ikeda, et al.
Continence (Amsterdam, Netherlands)|May 19, 2023
Targeting neurotrophin and nitric oxide signaling to treat spinal cord injury and associated neurogenic bladder overactivityYouko Ikeda, Irina Zabbarova, Pradeep Tyagi, et al.
Neurourology and Urodynamics|June 11, 2011
Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-AAnthony Kanai, Jean-Jacques Wyndaele, Karl-Erik Andersson, et al.
BJU International|July 23, 2016
The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivityMarcus J Drake, Anthony Kanai, Dominika A Bijos, et al.
Life Sciences|August 8, 2020
Excitatory effect of acotiamide on rat and human bladder: Implications for underactive bladder treatmentNishant Singh, Shinsuke Mizoguchi, Takahisa Suzuki, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Interventions|January 16, 2009
Targeted delivery of radioprotective agents to mitochondriaIrina Zabbarova, Anthony Kanai
Organic & Biomolecular Chemistry|January 6, 2007
Mitochondrial targeting of radioprotectants using peptidyl conjugatesAnthony Kanai, Irina Zabbarova, Andrew Amoscato, et al.
Life Sciences|December 7, 2021
Role of hyperpolarization-activated cyclic nucleotide-gated channels in aging bladder phenotypeNishant Singh, Irina Zabbarova, Youko Ikeda, et al.
Neurourology and Urodynamics|January 26, 2012
Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011Anthony Kanai, Irina Zabbarova, Michael Oefelein, et al.
Neurourology and Urodynamics|May 20, 2014
Do we understand any more about bladder interstitial cells?-ICI-RS 2013Anthony Kanai, Christopher Fry, Ann Hanna-Mitchell, et al.
Neurourology and Urodynamics|June 11, 2011
Sophisticated models and methods for studying neurogenic bladder dysfunctionAnthony Kanai, Irina Zabbarova, Youko Ikeda, et al.
Continence (Amsterdam, Netherlands)|May 19, 2023
Targeting neurotrophin and nitric oxide signaling to treat spinal cord injury and associated neurogenic bladder overactivityYouko Ikeda, Irina Zabbarova, Pradeep Tyagi, et al.
Neurourology and Urodynamics|June 11, 2011
Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-AAnthony Kanai, Jean-Jacques Wyndaele, Karl-Erik Andersson, et al.
BJU International|July 23, 2016
The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivityMarcus J Drake, Anthony Kanai, Dominika A Bijos, et al.
Life Sciences|August 8, 2020
Excitatory effect of acotiamide on rat and human bladder: Implications for underactive bladder treatmentNishant Singh, Shinsuke Mizoguchi, Takahisa Suzuki, et al.
Pageof 2